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Abstract
In response to the Office of Inspector General’s research report on atypical antipsychotic
off label treatment of elderly dementia residents in long-term care, the Centers for
Medicare and Medicaid Services developed a non-pharmacological intervention known
as the Hand In Hand training tool. This projects focus was on training the direct care
nursing staff with the Hand In Hand tool and evaluating for decrease in behavior and
psychological symptoms in their patients. A retrospective chart review was utilized for
the Minimum Data Sets tool Brief Interview of Mental Status (BIMS) and Mood
interview. Pre training and post training scores were analyzed using descriptive
statistical paired sample t test. No statistical significance was shown on the pre and post
BIMS or Mood scores. Six months of Pharmacy Review Summaries were collected and
averaged for pre and post medication prescriptions for residents during six months of this
project. No increase was found on the administration of atypical antipsychotics during
this period.
Keywords: Dementia, Off-label atypical antipsychotics
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CHAPTER I
Introduction
Non-Pharmacological Interventions Project: Treatment for Dementia
A major concern to healthcare of the elderly is the use of off-label atypical
antipsychotic medication to treat dementia. Risks associated with atypical antipsychotic
medications include confusion, sedation, postural hypotension, and increase in death
(Casey, 2011; Shekelle et al., 2007). Traditional medications for dementia are used and
in some long-term facilities there are non-pharmacological treatments such as music and
art therapy being used. More rigorous research in non-pharmacological management of
behaviors is needed to confirm their use in treatment of behavior and psychological
symptoms in dementia (BPSD) (O’Neil et al., 2011).
This capstone project focus was on a non-pharmacological intervention called
Hand In Hand training for care givers of residents with dementia, and producing
outcomes to show the need to reduce the use of atypical antipsychotic medications. The
Centers for Medicare and Medicaid (CMS) developed the Hand In Hand modules in 2013
to aid care givers in nursing centers with assessment and management of dementia
behaviors (Centers for Medicare and Medicaid Services, 2013). These modules
emphasize person centered care, communication, meeting the resident’s needs,
refocusing, and redirecting the resident during times of behavior and psychological
symptoms of dementia.
Dementia: what is it and what are the effects on people? According to the
National Institute of Health it is a disease that has many symptoms (National Institute of
Health, 2013). Dementia affects cognitive, emotional, behavioral functions, and even the
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personality of those with the disorder. Memory, language, and problem solving skills can
all be affected. Diseases of Alzheimer’s or Huntington’s can cause dementia and also
disorders of deficiencies in nutrition, tumors of the brain, and even medication reactions.
Residents can demonstrate symptoms of wandering, agitation, aggression, pacing,
irritability, and sleep disturbances. These can be present in the neuropsychiatric
symptoms of dementia (Ballard & Corbett, 2010).
The Hand In Hand training modules, developed by Centers for Medicare and
Medicaid Services (CMS), is for improving the management of behaviors in dementia
patients. The goal is to decrease the potential risk of decline and negative side effects
from antipsychotic medications in the elderly with dementia through training of staff
emphasizing person-centered care. This project implemented the Hand In Hand training
and gathered data to analyze outcomes of behavior and medication regimes post training.
Problem Statement
Powerful antipsychotic medications have been shown to cause serious side effects
in the elderly and increase the risk of death (Shekelle et al., 2007). Despite these
warnings many nursing care centers, where elderly residents with dementia reside,
continue to treat dementia residents with atypical antipsychotic medications. There are
few high grade level research studies to support the use of non-pharmacological clinical
treatments for dementia, which has led to increased management of behavior and
psychological symptoms in dementia through off-label atypical antipsychotics.
Justification of Project
From January 1 through June 30 of 2007, 14% or 2.1million elderly residents in
nursing homes had at least one claim for Medicare reimbursement of an atypical
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antipsychotic at a cost of 309,028,317 dollars (Appendix A). Of those claims, 83% were
for off-label use and 88% were being used in conditions against the Food and Drug
Administration (FDA) boxed warning (Appendix B). These erroneous claims totaled to
$116 million (Appendix C) (Office of Inspector General (OIG), 2011). A total of 22%
were administered against CMS standards for treatment of unnecessary drugs (Appendix
D) (OIG, 2011). The costs in both lives and dollars to the health care systems (Medicare,
Medicaid, and Insurance) are staggering (OIG, 2011).
As the baby boomer generation, those born from 1946 through 1964, continues to
age and join the healthcare system, this burden will increase by 76 million boomers
(Blumenthal, 2011). The trend in nursing homes is to favor the use of these drugs for
dementia treatment. Researchers have found that prescribing rates were directly linked to
residents’ characteristics (36%), characteristics of the facility (23%), and 81% to the
nursing home culture of prescribing (Huybrechts, Rothman, & Brookhart, 2012).
Staffing issues, problems with medication reconciliation, and family wishes also are
significant barriers to changes in treatment of dementia in the elderly. Resident quality of
life and independence helps to lessen the caregivers burden (Kurt, 2011). Stricter
monitoring of these drugs, assessments of side effects, and use of non-pharmacological
interventions can reduce risk to the patients (Lindsey, 2009).
Medicare Claims
Despite the evidence of the dangers of off-label atypical antipsychotic medication
use with the elderly, these drugs continue to be prescribed for elderly dementia residents
within nursing facilities. The claims for Medicare reimbursement produce evidence of
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the use of these drugs for behavioral and psychological treatments for diagnoses against
recommended use.
The Department of Health and Human Services (DHHS) Office of Inspector
General’s (OIG) report of May 2011 evaluated claims to Medicare concerning off -label
atypical antipsychotic drugs for nursing home residents 65 years or older during January
1-June 30, 2007 (OIG, 2011). The OIG’s concerns for increase in off label atypical
antipsychotic drug claims and their costs prompted them to ask the question whether
these medications were being used appropriately. Findings revealed off label use of these
drugs were being prescribed for treatment of dementia and not necessarily for
recommended use according to FDA.
Atypical Antipsychotics
Currently only eight antipsychotic medications are approved for treatment of
behaviors associated with schizophrenia and bipolar disorder (OIG, 2011). Part of the
regulation of the Centers for Medicare and Medicaid (CMS) provides protection of
residents from the use of drugs not warranted and the length and dosage amounts given.
Medicare uses the Minimum Data Sets (MDS) part B & D to identify the medication
claims. This instrument is done at least every three months on each resident (OIG, 2011).
This extensive review of Medicare claims included International Classification of
Diseases (ICD-9) codes for claims. Nursing home inpatient and skilled nursing home
data was compared over a six month period for transfers to other facilities. The
Prescription Drug Event (PDE) program data was examined, due to their summary not
individual dosages. Individual nursing home documentation included pharmacy review
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records, admission records, resident care plans, nurse’s notes, consultations notes from
behavioral monitoring, and MDS assessments.
The statistical reports are from the Office of Inspector General’s (2011) report on
off-label atypical antipsychotics for the Department of Health and Human Services.
(Appendix A-D) Findings indicated that 14% of the nursing home elderly had Medicare
claims for at least one atypical antipsychotic. Of those claims surveyed, 83% were for
off-label use and 88% were prescribed for conditions listed in the FDA warning box.
Erroneous claims were 51%, at a cost of $116 million. The atypical antipsychotics, 22%,
were given despite the standards that the CMS considers as unnecessary drugs.
Although only eight drugs are approved, physicians often prescribe off label and
the practice is permitted. The Department of Veterans Affairs found in 2009 that 60.2%
of these atypical anti psychological drugs being prescribed had no record of the diagnosis
for which it was being used.
Despite the CMS guidelines for using these drugs, the medical criteria for
accepted use were not applied. The CMS guidelines also required quality and safety
standards for nursing facilities. One such requirement is freedom from drugs that are not
necessary. According to the standards set by CMS and drug criteria, these off-label drugs
do not qualify for compensation for treatment. Findings revealed that off- label atypical
antipsychotic drugs were without adequate monitoring and were shown to be lacking any
indication of their use (OIG, 2011).
This report reviewed over eight million medication claims: of the claims
reviewed, 1,678,874 met criteria. A sample size of 700 was included in the report.
Office of Inspector General admitted limitations to the report including length of the

6

study, pharmacy did not provide the drug information, and clinical staff was not a part of
the evaluation.
Risks
In 2007, The Agency for Healthcare Research and Quality (AHRQ) studied and
concluded that these off-label drugs increase risk of death for dementia residents. Why
are these drugs so dangerous in the elderly? The answer lies within the changes to their
bodies’ systems. In people 65 or older, the systems such as cardiovascular, liver, and
kidney functions show the most profound effect from the impact of these drugs. The
multi-organ inability to function at full capacity makes them more vulnerable and the
drugs upset the balance of their health. Due to sensitivity in the brain’s receptor sites and
decreases in function of the brain, there are serious outcomes from use of the
benzodiazepines, antidepressants, and antipsychotics.
These drugs can actually increase confusion, sedation, and postural hypotension
in the elderly. Older resident often have poly-pharmacy medication regimens which also
increases risk and adverse responses to these types of medications. The imbalance of
their homeostasis and cognitive impairment further complicates therapeutic effects of
these types of medications. Drugs often lose therapeutic effect from increasing dosages
leading to toxic effects (Casey, 2011). In the OIG (2011) report, the failure of monitoring
the drugs for reduction was significant to the safety issues for prescribing. Nonpharmacological interventions are the alternative means when dealing with the behaviors,
as recommended by the OIG (2011) report.
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Purpose
The purpose of this capstone project’s focus was on training direct care staff to
utilize non-pharmacological interventions in management of the elderly with dementia in
long term care. The goal was reduction in behavioral and psychological symptoms and
potentially to illustrate the need to decrease usage of atypical antipsychotic drugs.
Project Question
Can non-pharmacological intervention training of direct care staff decrease
behavior and psychological symptoms in elderly dementia residents and potentially
demonstrate a need for reduction in atypical antipsychotic medication use?
Definition of Terms
The following are definitions of terms referred to in this capstone project paper.
The terms are used to define the symptomatic disorder of dementia and the descriptive
term of the classification of medications that the elderly with dementia are being
prescribed.


Dementia: not specifically a disease but symptoms from many disorders
like Alzheimer’s or brain tumors that affect the mind, behavior,
personality, or emotional stability. It can affect memory, cause emotional
outbursts and agitation, and change personality (Dictionary.com).



Off-label atypical antipsychotic: second generation drugs that are given
for other disorders not specific for the diagnosis for schizophrenia or
bipolar disorder (Kohen, Lester & Lam 2010; Shekelle, et al., 2007).
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Summary
The capstone project addressed the use of atypical antipsychotics for dementia
and attempted to add support for the use of non-pharmacology intervention. The training
implemented the Hand In Hand training to affect behavior and endeavored to demonstrate
the need for non-pharmacological interventions in the treatment of dementia in the
elderly.
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CHAPTER II
Research Based Evidence
Effects of atypical antipsychotics on the elderly can be a serious risk. The
Agency for Healthcare Research and Quality (AHRQ) compared efficacy of the off label
atypical antipsychotics in their 2007 report (Shekelle et al., 2007). In this executive
summary of findings, the risks were cardiovascular, increase risk of death, and extra
pyramidal symptoms. Studies included 15 placebo-controlled trials, and a large head to
head placebo controlled trial. The AHRQ concluded that the risk of death was small but
so was the benefit of the off label atypical antipsychotic drugs and felt more information
was needed about the death risks and found that conventional or typical antipsychotic
drugs were potentially more risky. The findings indicated not enough high level research
had been done to prove efficacy of atypical antipsychotics, and until evidence was
available no one could conclude safety and efficacy of their use. These second
generation antipsychotic drugs continued to be prescribed despite the questions of
efficacy and safety.
Review of Literature
A review of the literature by Kohen et al. (2010) of the efficacy and safety of one
of the treatments of a second generation antipsychotic drug aripiprazole (Abilify), had
little evidence to support use of the drug but did not discount Abilify. The suggestion
from the review was that Abilify may be better than other drugs due to its metabolic
benefits. The delusions, psychosis, and hallucinations accompanying the drug were
considered as related to dementia. In three 10 week studies of 487 nursing home
residents, there were no significant outcomes between the treatment with Abilify and
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placebo with 256 residents. Kohen et al. (2010) conclusions felt that second generation
antipsychotics are greater risks to the elderly and not treating in mild dementia might be a
practical choice. Additional comparative studies involving non-pharmacological
interventions and atypical antipsychotics would provide possible options for treating the
mild dementia patient. There is not enough research evidence to decrease the use of these
drugs in dementia or treat mild dementia effectively. Warning labels from the FDA have
not prompted a reduction in the use of the off-label atypical antipsychotics.
Safety and Efficacy
Kim, Brown, Ding, Kiel and Berry (2011) questioned safety in other medications
commonly given to residents with dementia and Alzheimer’s dementia such as
cholinesterase inhibitors and Memantine. A RCT meta-analysis was conducted to
examine the safety and fall rates associated with the treatments using both drugs. This
study considered the impact of falls, fractures related to falls, syncopial incidents, and
injuries that were accidental (Kim et al., 2011). Of the 156, RCT considered only 54
were eligible due to lack of data on adverse events related to falls. Findings indicated
that cholinastrase did increase risk of syncope, but no effect related to falls, fracture, or
accidents. Memantine actually had beneficial effects on fractures, a surprising finding.
The findings were not conclusive due to under reporting and decreased outcome events
available. The study only looked at two common drugs administered to dementia
residents and their side effects. More research was needed to include the eight most
prescribed atypical antipsychotics and their effects on the elderly.
Maher et al. (2011) conducted a systematic review and meta-analysis to address
the efficacy of off- label use of atypical antipsychotics for dementia. The review
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revealed that from 1995 to 2008, off label atypical antipsychotics doubled in prescribing
rates from 6.2 million to 14.8 million. The eight drugs investigated were aripiprazole,
asenapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and
ziprasidone. The systematic review revealed that death risks increased by 3.5% with the
use of these drugs compared to 2.3% in placebo. With olanzapine and risperidone, there
was greater occurrence of cardiovascular, vasodilatation, and edema symptoms.
Risperidone had significant signs and symptoms for increased stroke risks. Health risks
were increased incident of diabetes, sedation, fatigue, extra pyramidal symptoms, urinary
tract infections, decreased cognitive functions, orthostatic dizziness, confusion seizures
and headaches. Overall, of the four large studies done, the risk of death increased with
conventional antipsychotics: two smaller studies showed increased with both types of
drugs, and the findings of increased mortality were found for both classifications of
drugs. A small but statistically significant benefit for treatment in behaviors in dementia
patients was found in aripiprazole, olanzapine, and risperidone but harmful effects of the
drugs were also statistically significant in the elderly. Maher et al. (2011) concluded that
off-label atypical antipsychotic drug use in the elderly with dementia is associated with
adverse outcomes and are statistically significant in increasing risk of death, showing that
use of these drugs and adverse effects are related. Decisive research on the atypical
antipsychotics and their serious risks to the elderly with dementia was now evident.
Despite warnings from the FDA and mounting evidence from researchers prescribing of
these drugs to dementia residents increased.
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Evidence of Use
Evidence was available that the off-label atypical antipsychotic drugs were being
widely used for dementia in the elderly. The National Veterans Administration (VA) set
out to discover how many elderly veterans were receiving these drugs for dementia. A
multivariate logistic regression method was done on the VA database looking for at least
one prescription of off label use from 2006 until 2007. The study of off-label use of
antipsychotic drug use in the VA system revealed evidence, like many other care settings,
that the elderly with dementia are commonly prescribed these drugs (Leslie, Mohamed, &
Rosenheck, 2009). Seven drugs were examined in this study: aripiprazole, clozapine,
olanzapine, quetiapine, risperidone, and ziprasidone. Diagnosis was considered with
schizophrenia and bi-polar being excluded. The sample size was 279,778; of that number
60.2% (168,442) had no diagnosis to be prescribed the drugs. Prescribing for posttraumatic stress syndrome (PTSD) was over 40%: 39.5% was for minor depression,
23.4% received the drugs for major depression, 20% for anxiety: 20% for alcohol and
15.1% for drug dependency. The study acknowledged the fact that the ratios of patients
in groups were over 100% and the extent of the co-morbidities within the patient
population. In quetropine use, the largest group receiving the drug was organic brain
syndrome and Alzheimer’s dementia. If the veteran had PTSD, psychosis or organic
brain syndrome or Alzheimer’s, their odds for being prescribed these drugs increased
(Leslie et al., 2009). Although indication for use of these drugs in dementia was absent,
prescribing rates continued to increase. The OIG (2011) report was now verified by the
VA report that nursing home dementia residents have been administered these atypical
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antipsychotics and the prescribing rates have varied across the country regardless of
indication of use.
A systematic review meta-analysis conducted by Chen et al. (2010) supported the
evidence of variation rates in the nursing homes in the United States (U.S.). Data was
collected from a national database of MDS forms and prescription data records. The
forms were collected from 2005 through 2006. Sample size was 16,586 from 1257
nursing homes and pharmacy claims were 66,181. In 2006, more than 29% of nursing
home residents received at least one antipsychotic drug with 32% having no indication
for use (Chen et al., 2010). When facilities have a high rate of prescribing, it was found
that the resident would be 1.37 times more likely to receive these drugs than those
residents in low prescribing facilities. Race was also an indicator of prescribing rates and
confirmed in the VA research. Chen et al. (2010) found the white race was 11% more
likely to get these drugs than blacks. Of those without psychosis, whites were 30% more
likely than blacks and 22% more likely than Hispanics. Dual eligible patients, those
with Medicare and Medicaid, were also more likely to receive antipsychotic drugs. Once
again the conclusion of this study supported evidence of variation of prescribing in
nursing homes related to previous prescribing rates and race.
In 2012, the Beers Criteria for potentially inappropriate medications (PIM) for
nursing home residents was revised by an expert panel of geriatricians and
pharmcotherapists (American Geriatrics Society, 2012). The systematic review and
evidence grading of classification of PIM’s was to update the previous Beers Criteria.
This update was considered necessary based on the evidence that despite warnings these
drugs continued to be first line treatment for the elderly. The drugs were classified in

14

three categories: those medications that were potentially inappropriate for use, those
drugs which exacerbated existing conditions and those that needed caution when
prescribing for the older adult. The new Beers Criteria linked with the American
Geriatric Society allows for best practice and clearer system updates from experts to
guide policy, research, and clinical practice (American Geriatric Society, 2012). A total
of 53 medications are included in the updated Beers Criteria, under the three categories of
PIM. The Beers Criteria is considered a clinical guide to drugs that are more harmful than
beneficial to the older adult.
Regardless of the warnings, neurologists have many questions about the OIG
report and the overuse of these drugs. These off label antipsychotic drug use are seen as
either a means of restraint or a way to save money by using cheaper non-conventional
medications (Samson, 2011). Dr. Louis Cooper, professor of neurology at Harvard
Medical School, sees these drugs as medical straightjackets and is largely unmonitored
once given. Dr. Cooper felt a lack of adequate funding to manage the problem residents
in nursing homes was a major rationale in using the atypical antipsychotic drugs
(Samson, 2011). Dr. Nair, chief of Neurology at the Alzheimer’s Medical Center,
thought the data was incomplete and felt conventional drugs were more harmful. He felt
this was a cost issue, and since no drug has been approved for behavior in dementia, the
report was generated to cut costs. Dr. Nair felt these drugs should be used when nonpharmacological attempts have failed and the behavior becomes unmanageable (Samson,
2011).
Although there was a divide on the use of these drugs and how they are
prescribed, one issue remained the same: there was a need to have recommended
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treatments that are safe and effective when treating the elderly with dementia. With such
differing opinions and lack of comparative studies for pharmacological and nonpharmacological treatments, what is the recommended treatment for elderly residents
with dementia?
Treatment Recommendations
In 2006, the VA Office of Geriatrics and Extended Care (OGEC) directed a
committee to ask key questions concerning dementia care for the veterans related to nonpharmacological treatment in behaviors compared to pharmacological treatments (O’Neil
et al., 2011). Three key questions were considered: the effectiveness, safety, and costs of
non-pharmacological treatment in dementia versus pharmacological treatment. (O’Neil et
al., 2011). Studies included cognitive, exercise, animal assisted, massage, music, animal
assisted therapy, memory, acupuncture, aromatherapy, and behavioral management
interventions were all considered. Other areas reviewed were related to techniques for
prevention of wandering, agitation, and inappropriate sexual behaviors using barriers,
environmental modifying, and distraction. Conclusions were considered varied as to
effectiveness of treatment of behavior and psychological symptoms of dementia (BPSD).
In the cognitive area, validation therapy showed some significance compared with other
therapies. Aromatherapy showed some promise in decreasing agitation: no differences
were found for exercise, massage, or acupuncture and only mixed reviews for light
therapies. No evidence on the environmental modification and unclear evidence in the
barrier or other treatments for behaviors management. Very little information was found
concerning cost related research. Overall this review suggested more rigorous evidence
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is needed using blinding methods and management of treatments being standardized to
produce consistent results.
Khan and Curtice (2011) conducted a pilot project in the United Kingdom to
produce evidence for non-pharmacological treatment to be used initially. It was
conducted in four care homes across the nation. Sessions were held for six months and
each home had six sessions conducted. Training was done to prepare caregivers and staff
with knowledge to intervene with non-pharmacological techniques of relaxation,
distraction, nostalgic thoughts and art, music therapy with person centered focus.
Monitoring also occurred with all psychotropic medication therapy.
Significant findings were the need for a team approach, effective training was essential in
dealing with BPSD for all staff and avoidance of an easy quick solution using
psychotropic drugs to manage BPSD (Khan & Curtice, 2011). Lindsey (2009) revealed
in her systematic review the importance of knowledge and a collaborative relationship
between nurses and physicians. Person centered care is part of the emphasis placed on
nurses and all caregivers to improve quality and safety for the patients with dementia.
Person-Centered Care
The need to individualize care is part of person-centered care model that has been
instituted in most healthcare settings. Suhonen, Alikleemola, and Katajisto (2010)
descriptive design study considered individualized care with the goal to describe the
perceptions of nursing in the long term care and long term in-patient wards. The
Individualized Care Scale-Nurse was used to collect data from 283 nurses. In the clinical
situations, nurses felt they were using individualized treatment and care of their elderly
residents. They recognized that individual control of decisions was lacking in and during

17

nursing activities. Although nurses perceived they provided individual care, generally
this was not evident in the assessment of practice overall. This study did produce
improved results on individualized care from nurses compared to previous studies. In the
treatment of the elder dementia resident, individualized person-centered care given by
knowledgeable nurses is imperative to monitoring and decreasing unnecessary
antipsychotic drug use for the improvement of their safety and quality of life.
In Zee and Burkett’s (2008) critically appraised paper of behavior management,
they proposed that once a person begins into dementia behavioral problems, it is usually
two years to nursing home placement. Behavior management then becomes an essential
part of treatment. One of the Office of Inspector General’s (2011) recommendations was
alternative methods for compliance, which included education and training for nursing
home staff in dealing with behaviors in dementia. Environment plays a key part in
decreasing behaviors (Zee & Burkett, 2008). These behaviors can include pacing,
wandering, agitation, aggression, and depression. Some of the suggestions to decrease
these behaviors include a reduction of choice, various cues, and redirecting. Nonconfrontational management of behaviors is important and always with resident safety in
mind. In conclusion Zee and Burkett (2008) emphasize treating underlying needs of the
resident, if needed treating BPSD with low dose antipsychotic drugs and only with
atypical antipsychotics when benefits are clearly evident and there are few side effects.
Ballard and Corbett (2010) suggested that first line treatment should be nonpharmacological interventions. This systematic review considered meta-analysis and
cohort studies previously done. When compared to reviews on non-pharmacological
studies, systematic reviews of 162 studies and RCT were evaluated. Ballard and Corbett
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(2010) found that person-centered care, enjoyable activitie,s and exercise decreased
BPSD. Treatment with low dose atypical antipsychotics when needed has not been ruled
out as a treatment but is not suggested as a first line treatment. It is the project
administrator’s opinion that non-pharmacological interventions are the alternative
interventions when dealing with the behaviors, as recommended by the OIG (2011)
report.
Cognitive Stimulation Therapy
Aguirre et al. (2012) randomized control study of Cognitive Stimulation Therapy
(CST), followed 272 dementia participants for seven weeks to determine the reasons that
might predict their response to the CST. The residents were from multiple settings
including care homes, day centers, and mental health centers located within the
communities. The participants were randomly selected into two groups, decreasing the
intra class correlation, with both groups receiving the CST. The interaction included
exciting language interchanges, reminiscing, thinking sessions with points of references,
and with a person-centered focus. Quality of life, cognition, behavioral disturbances, and
activities of daily living (ADL) were all measured. Results for the study revealed when
compared to previous RCT of cognitive stimulation therapy, this study showed
significant changes in scoring. Quality of life indicator scores increased after CST.
Significance of this study could lie in the person-centered approach, as Lindsey (2009)
review stated. An unexpected finding was how 80 years old and older had scores that
showed positive effect from cognitive stimulation therapy. Reflections from researchers
concerning the age group related to overall lack of stimulation compared to those
younger and changes that occur with age, not dementia related, have to be considered.
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Exercise
A non-pharmacological intervention that has shown some promise is exercise. At
the time of publication, Cerga-Pashoi et al. (2010) was conducting an ongoing study
implementing incremental walking exercise with 146 participants. Two randomized
groups participated, one received the walking and one received treatment as usual. The
program is for 6-12 week periods, with a 20-30 minute walking regime with a qualified
exercise therapist. Measures were taken for physiological and psychological effects at
the 6 and 12 week timeframes. Zee and Burkett (2008) found that indications are that
exercise is neuro-protective for reducing risk in dementia and has shown promise in
dementia care. The NeuroPsychiatric Inventory tool (NPI), developed for assessment of
BPSD is being used in the assessment of areas of quality of life, usage of psychotropic
medications , placement into care facility, level of transience of life, and burden that the
care givers felt (American Psychological Association, 2013). This study, if outcomes are
positive, would add to the evidence, using a valid and standardized tool. The larger
systematic reviews felt previous trials were deficient in using valid tools.
Aromatherapy
The non-pharmacological intervention aromatherapy has shown some
effectiveness with dementia in the large systematic review by the VA (O’Neil et al.,
2011) and the review by Ballard & Corbett (2010). In both reviews, aromatherapy had
positive effects when treating agitation in dementia. Bidewell and Chang’s (2011)
systematic review on dementia treatments in residential care included aromatherapy.
Agitation was defined as an unmet need and relationship of the resident to the
environment, whether it was an internal or external stimuli. There were 241 studies out
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of 3,100 that met criteria. Lavender was found in one review to also have positive effects
on BPSD. However, similar to other reviews, only one study was felt to be rigorous
enough to produce evidence to show a favorable response when using aromatherapy for
agitation. Bidewell and Chang (2011) also considered aromatherapy as a
pharmacological treatment, which was an unexpected conclusion. Overall, the
conclusion from the systematic review was that no one treatment method was found to be
effective and the high grade level studies remain scarce. As with many other nonpharmacological studies, the trials are not considered high grade to produce the evidence
needed.
Music
Music therapy has been used as a non-pharmacological intervention with
dementia residents. In the previous VA systematic review (O’Neil et al., 2011) music
therapy had questionable results. Cook, Moyle, Shum, Harrison, and Murfield (2010)
randomized cross over design study questioned music and the validity of treatment for
agitation in dementia and to improve emotional and quality of life. Participants were
placed in music or reading groups and then switched at half way point. The study was
conducted in two mixed long term care facilities and researchers were blinded to patient’s
characteristics. The analysis of the study revealed no statistical significance in either arm
of the study to decreasing agitation in the residents. There was an increase in verbal
aggression and researchers felt that the therapies helped patients find their voice again.
Nevertheless, the non-pharmacological intervention had a significant result in that both
interventions caused an increase of verbalization of residents.
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Communication
Communication is a powerful tool that is used every day by all people and
effective communication is essential to all who provide care to others. Williams,
Herman, Gajewski, and Wilson (2009) conducted an observational study to address the
use of elderspeak and its effect on dementia residents. Elderspeak, defined as
infantilizing communication (baby talk), is used during ADL’s with the dementia
residents often by the nursing staff giving care (Williams et al., 2009). The study
examined the use of elderspeak and the correlation to resistance to care (RTC) compared
to normal talk with dementia residents. RTC was defined as aggression, vocal eruptions,
and pulling away. The study design was analyzed using psycholinguistic, observational,
and behavioral methods. Video and audio recordings were conducted on 80 interactions
between staff and residents during ADL’s. Measurements were made using the
Systematic Analysis of Language Transcripts (SALT) computer program and the
Resistiveness to Care Scale (RTCS). Conclusions were that a temporal relationship does
exist between elder speak and increase RTC behavior in comparison to normal talk and
RTC.
Recommendations have been made to include non-pharmacological treatments for
patients with early stage/mild to moderate dementias. Burgener, Buettner, Beattie, and
Rose (2009) consensus report supports community based treatment modalities, using non
pharmacological interventions, to treat dementia on a national level. The report was
based on 150 research articles using non-pharmacological interventions in six areas. The
areas included support early in the disease, cognitive interventions, and exercise
programs that involve writing and art, promotion of health, program utilizing sleep, and
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hygiene aid. It was determined in the report that increased access to community based
interventions would decrease the stigma that society places on dementia, reduce the over
medication of these people, and help people to achieve more normalized lives. Some
studies suggested that these interventions can slow cell destruction and maintains some
neural abilities. Giving the long term programs accessibility to help maintain dementia
patients in the home improves the quality of life. Identifying the caregivers as essential
partakers of the therapies also would increase positive outcomes. Other suggestions in
this report were the application of evidence based protocols for clinical practice for nonpharmacological interventions to be a part of treatment for early stage dementia.
Goal
The American Health Care Association (AHCA) and the National Center for
Assisted Living (NCAL) started a quality initiative in 2012 to improve the quality of care
in skilled nursing homes and assisted living communities across the United States
(American Health Care Association & National Center for Assisted Living, 2013). These
goals included the reduction of off-label antipsychotics by 15% nationwide. This quality
initiative was in line with the Inspector General’s report, Department of Health and
Human Service, the Senate Committee on Aging, and CMS goal of quality of life issue
for residents and families. The Hand-in-Hand project attempted to produce outcomes to
support the use of non-pharmacological interventions in treatment of dementia (American
Health Care Association & National Center for Assisted Living, 2013).
Literature Gaps
Literature gaps were in the non-pharmacological studies, studies being conducted
did not produce rigorous high grade evidence to support its use in clinical treatment.
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Many studies were of qualitative design and were not random controlled trials that
produced enough empirical data. A major gap in the literature was the cost comparison
between using pharmacological or non-pharmacological interventions to treat dementia.
Pharmacological costs were available but very few, if any, studies were mentioned in the
literature on actual costs for non-pharmacological treatments.
Strengths and Limitations of Literature
Strength of the literature for this review was the amount of data from systematic
reviews and the multiple databases used for the research. Multiple databases used for
literature including Pub Med, Cumulative Index to Nursing and Allied Health
(CINAHL), PsycInfo, Cochran Database of Review of Effectiveness (DARE), Cochrane
Central Register of Controlled Trials (CENTRAL) and MEDLINE. Reputable
governmental and private agencies conducted many of the reviews, especially the
pharmacological reviews. Several of the studies were large studies with large samples
with many levels of evidence.
Limitations in the literature were heavily weighed on the non-pharmacological
research. Many of the reviews spoke of the lack of high grade evidence, problems with
the scientific method of the studies and an overall lack in the literature of studies being
conducted or evidence available to support non-pharmacological interventions in the
treatment of dementia.
Theoretical Framework
The conceptual framework for this project is Betty Neuman’s Care Systems
Model that is based on relationships of stress, response to the stress and constructs a new
system to deal with the stressors (Neuman Systems Model, 2013). The system is
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considered universal in its design and adaptable in many ways. Neuman’s design is
centered on the premise that three lines of resistance: one representing the internal
factors, normal line helping the patient maintain equilibrium, and a flexible one to help
quickly change and adapt (Neuman Systems Model, 2013). In the theory, the nurse’s
interventions are involved in prevention. These preventions are primary, secondary, and
tertiary. Normal lines preventions help protect, secondary preventions give strength to
the internal lines, helping the reactions and resistance to stressors. Tertiary helps the
patient to adapt, become more constant and return to a state of wellness (Neuman
Systems Model, 2013). This capstone project used the primary prevention by using nonpharmacological intervention for management of stressors. By using communication and
distraction methods the internal lines that react to stress can be managed by staff,
utilizing the secondary prevention method in Neuman’s theory. In the tertiary level of
the project, consistent reinforcement of the non-pharmacological interventions help the
resident adapt, maintain and return to their individualized equilibrium.
Please refer to Figure 1 for Neuman’s Care Systems Model.
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Summary
Current literature has large studies and multi-level grade research in the
pharmacological treatment of dementia with antipsychotics. Atypical antipsychotic
drugs should be limited, closely monitored, and discontinued when possible when
associated with treatment for dementia in the elderly. Costs in dollars and quality of lives
will have a far-reaching impact on society. One consideration in effective treatment of
BPSD is by non-pharmacological interventions. The challenge today is to demonstrate
positive outcomes using non-pharmacological interventions and generate data for
potential savings in dollars and lives.
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CHAPTER III
Project Description
Project Implementation
The capstone project included a retrospective chart review on the antipsychotic
drug use in the long-term care facility. Information from the executive summary of
consultant pharmacists report on tracking psychoactive and hypnotic drug utilization was
obtained. This report is compiled monthly and three consecutive months were used for
needs data. The executive summary also used post project implementation to determine
any changes in medication orders.
A Brief Interview of Mental Status (BIMS) is completed on every new admission
into the nursing facility at five days, 15 days, at 30 days, and again at 90 days. BIMS is
completed electronically on all residents and also by exception, when changes occur in
behavior. The BIMS test is a 15 point measure of both memory and orientation (Chodosh
et al., 2008). Data was collected at the beginning of the project from the BIMS on the
above mentioned areas. Previous BIMS data provided a baseline to analyze any changes
in the areas of cognition and mood after implementation of the training in Hand In Hand.
Data was compared on all new admissions prior to training and within the 90 day period
following staff training.
The Center for Medicare and Medicaid Services (CMS) (2013) has recently made
available Hand In Hand training modules to all nursing homes to emphasize personcentered care and prevention of abuse in dementia persons (CMS, 2013). The Hand In
Hand modules are focused on the principles of maintaining a process that includes the
ability of the care giver to listen, test, reevaluate, change, and adapt their methods and
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organization style to de-institutionalize the nursing home environment (CMS, 2013).
Emphasis is placed being where the resident is, listening skills, redirecting behaviors,
recognizing needs, and adapting the care to meet the resident’s needs. The Hand In Hand
was developed for primary caregiver training but CMS is suggesting that all personnel
take part in the training. In this training, personnel within the facility that have
interaction with residents with dementia received the training. Hand In Hand training
session are divided into six one-hour sessions with DVD scenarios and a debrief session
afterwards. Administration assigned staff during several two-hour sessions throughout
the day to attend. Training took place over a two week period until all scheduled direct
care staff completed a session. Self-evaluations were included in post training as part of
the modules.
Data was collected on the residents’ Brief Interview of Mental Status (BIMS) and
executive pharmacy summaries for the following three months. Resident records
including BIMS, pharmacy reviews were also evaluated before and after the training was
completed. Statistical data was analyzed including demographics, cognitive status, and
mood from the BIMS. The BIMS tool is considered to be a good tool for cognitive
assessment and accurate in identifying impairments in cognition (Chodesh et al., 2008;
Tucker, 2013). Pharmacy records were analyzed before and after for change in
medication treatments.
Setting
The setting is in a long-term rehabilitation nursing center in the eastern United
States. The facility is corporate owned and has approximately 130 Medicare and
Medicaid funded beds and 20 private pay beds available. Long term stays and short term
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rehabilitation services are delivered in the facility. It serves a community of
approximately 270,000 people not including rural areas within close proximity.
Sample
The sample size for chart reviews was fifty (N=50) residents that were being
treated with atypical antipsychotics or other sedative/hypnotic medications. The sample
size did change at implementation of the capstone project, due to new admissions,
discharges and mortality rates.
Project Design
Phase I
This project began with the chart review of data from the Brief Interview of
Mental Status and pharmacy review records for baseline data. Implementations of the
Hand In Hand training modules, in the nursing facility, were then scheduled.
Stakeholders are residents, family members, staff, providers, and owners of the facility.
The goal was to train 80% of staff including nursing, nursing assistants, administration,
and ancillary staff. Six Hand In Hand training modules were conducted over a three day
period at the beginning of October, 2013. Modules are self-contained with debriefing
sessions and self-evaluation for the participants.
Administrative staff ensured all patient information was de-identified from the
facility for the capstone project. A numerical code was implemented to represent each
resident in the project. Brief Interview of Mental Status (BIMS) was used for data
collection on cognitive and mood data, as well as, monthly Pharmacy Review Summaries
used to analyze the atypical antipsychotic drugs given monthly.

30

Phase II: Data Collection and Analysis
Phase II was done post training, data from Brief Interview of Mental Status
(BIMS) evaluations and pharmacy executive summaries were obtained at mid-January,
2014. Data was collected from the cognitive and mood elements of the BIMS.
Pharmacy Review Summaries were collected from the previous three months, before
training and for the three months post training. Statistical analysis using Statistical
Package for the Social Sciences (SPSS) version 22 software was used to evaluate the
data.
Phase III: Defense
Project findings were written for dissemination and an oral presentation given.
Protection of Human Subjects
All records of nursing facility, residents Brief Interview of Mental Status, and
Pharmacy Reviews were de-identified and Institutional Review Board approval was
obtained prior to implementation of the project.
Instruments
The Brief Interview of Mental Status (BIMS), Mood data tool, Pharmacy Review
Summary and Hand In Hand training modules were used in the project data collection.
The Centers for Medicare and Medicaid provide the BIMS and Mood tools, as part of the
Minimum Data Set, for the nursing center to evaluate residents. This tool is done
electronically and on the intranet within the facility. BIMS and Mood data was accessed
and data retrieved using the facility system. Pharmacy reports are generated monthly by
the pharmacists providing medications for the facility and distributed to facility
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Administration. The administration staff provided copies of six months of Pharmacy
Review Summaries for the project.
Data Analysis
Statistical Package for the Social Sciences (SPSS) version 22 analyzed the
demographic, cognitive, and mood of each sample. Data was analyzed by descriptive
statistics using the paired sample t test. A p value of <.05 was considered significant for
all tests. Pharmacy review records from previous reviews and post training reviews were
analyzed for average and variances.
Timeline
At the beginning of October, 2013, the most recent quarterly Brief Interview of
Mental Status (BIMS) and Pharmacy Review Summaries were collected on the dementia
patients in the nursing facility. Implementation of the Hand In Hand training modules
began in October 2013. Post training BIMS and Pharmacy Review Summaries were
collected. Data was then analyzed using SPSS. Please refer to Project Timeline in
Figure 2.
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Budget
The following were the costs for the project. Materials and supplies for the Hand
In Hand training were available from the nursing facility. Costs for transportation to the
facility were incurred; approximately $40 for gas times the training and data collection
was approximately $200 dollars. Data collection is already in place through the nursing
home Brief Interview of Mental Status (BIMS) and Pharmacy Review Summaries.
Administrative staff were available to run reports. These are standard reports readily
available at no additional costs. A statistician to analyze the data was available at no
cost.
Limitations
Limitation of this capstone project included sample size of residents with
dementia and the setting, one nursing home facility. Potential limitations can also be
related to accuracy of BIMS data collection from the MDS, due to subjectivity of the
MDS nurse. A time limitation was also a factor since residents records were analyzed for
three months of data. The study would benefit from a larger sample size of dementia
patients in multiple nursing facilities and a time frame of at least one year.
Summary
As costs continue to rise for health care across the United States and the
population ages, new and innovative ways to manage care, increase quality, and contain
costs will be essential for all people. Atypical antipsychotics have been shown to increase
risks, increase costs, and lower the quality of life in the elderly with dementia. Nonpharmacological studies have shown some promise in the treatment of dementia. This
project was intended to demonstrate that the non-pharmacological Hand In Hand training
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might potentially modify behaviors and help to reduce the high risk atypical antipsychotic
use for BPSD. The focus was to confirm the impact that the Hand In Hand intervention
had on behavior and disseminate the results to medical staff for potential changes to
medication regimens. In the future, these implications may help guide atypical
antipsychotic medication reduction or provide direction for short term medication of
atypical antipsychotics for dementia residents.
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CHAPTER IV
Results
The Hand In Hand capstone project was designed to use a non-pharmacological
training with long-term nursing staff to improve behavior and psychological symptoms in
dementia (BPSD) residents. A pre and post chart review was done after training with the
staff, to evaluate the Brief Interview of Mental Status (BIMS) and mood scoring on
residents. Cognitive function and mood are determined in the BIMS tool. Pharmacy
Review Summaries were also evaluated to determine changes related to antipsychotic
medication orders. The descriptive statistics paired sample t test method was used to
determine any changes in scores of the BIMS tool.
Measures
The Brief Interview of Mental Status (BIMS) measures cognitive patterns with a
scoring range of 00-15. The score 99 or four or more 0’s is given by the coder on the
BIMS tool for any resident unable to complete the questions. Ranges for scores are
graded on a scale of: 13-15 indicates cognitive intact function, 8-12 there is moderate
impairment, and 0-7 indicates severe impairment. The Mood tool measures in two
categories i.e. symptom presence and frequency. The tool scores each side. The
“presence” side has a total of 0(no) or 1 (yes). The “frequency” score ranges from 0 to 3,
depending on how many total days the symptoms occur. Together the scores add to a
range from 00-27. The lower the score (00) indicates no problem with mood and the
higher the total score the more indication of increased mood problems. Residents are
asked the nine questions concerning depressed feelings, little interest, poor appetite,
suicidal thoughts, sleep problems, loss of energy, bad feelings of self, problems with
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concentration, and noticeable changes in movement or speech. These are scored on the
frequency of occurrence. If the resident is unable or unwilling to respond to the questions
they receive a 99 or a 4 zero’s score on the Mood tool.
Sample
In total, only six (N=6) dementia residents from the Pharmacy Review Summary,
on residents receiving mood-altering medications, met the inclusion criteria. Average
age ranged from 81 to 94 years old, with one (N= 1) male and five (N=5) females.
Non-respondents
Fifty (N=50) charts were reviewed for mood altering medications, dementia
diagnosis, and atypical antipsychotic medications. Of the charts reviewed, seven (N=7)
residents were short-term rehabilitation and were discharged and three (N=3) dementia
residents died during the project. The residents that did not meet criteria due to a
depression diagnosis, although they received atypical antipsychotic medications, were a
total of three (N=3). Five (N=5) residents with the dementia diagnosis were receiving
sedative or hypnotics. Nineteen (N=19) did not meet criteria, either the dementia or
atypical antipsychotic medication regime, for the project. There were two (N=2)
residents receiving the medications for approved diagnosis of schizophrenia and one
(N=1) had a psychosis that was receiving the atypical antipsychotic medications. One
(N=1) resident was receiving atypical antipsychotic medication without any related
diagnosis. There were two (N=2) residents who had dementia diagnosis and atypical
antipsychotic medication but were unable to complete the Brief Interview of Mental
Status (BIMS) or Mood tool. One (N=1) resident had pre BIMS and Mood but no post
documentation. Please refer to Table 1.
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Table 1
Chart Review of Targeted Sample
Charts reviewed
Discharged
Deaths
Depression Diagnosis
Sedative/Hypnotic Medications
Did not meet criteria
Approved diagnosis
No related diagnosis
Unable to complete tool
No documentation for Post results
Total cases utilized (N)

50
7
3
3
5
19
3
1
2
1
6

Pharmacy Review summaries were collected for three months prior to training
and for three months post training. The number of residents receiving atypical
antipsychotic medication was collected for three months prior to training and for three
month post training. The numbers were then averaged for pre and post months.
The project goal for Hand In Hand training was 80% of facility staff. Training
took place in the facility over three days and a total of 101 attended out of 175
employees, (57.7%) attendance. Direct care nursing staff attendance was 67, (66%)
attendance. Other staff members attending made up the 34% of the Hand In Hand
training classes. Please refer to Figure 3.
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Figure 3. Hand In Hand Training Attendance by Staff

Descriptive Statistics
A retrospective chart review was used for pre and post Brief Interview of Mental
Status (BIMS) and Mood scores for this project. A paired-samples t-test was conducted
to compare the intervention of non-pharmacological Hand In Hand training, comparing
the pre-BIMS and Mood scores and to the post training BIMS and Mood scores. There
was a statistical significance between the scores for pre average BIMS (M=7.438, SD=
4.0975) and post average BIMS score (M = 4.750, SD = 2.3611) scores; t (5) = 3.064, p =
.028. The Mean scores may indicate a decrease in cognitive function level based on
scoring criteria. The scoring criteria rates 13-15 as cognitive function intact, 8-12 as
moderate impairment and 0-7 as severe impairment. The variance in pre and post Mean
indicate a decrease in scoring. Please refer to Table 2.
Although the paired sample size was inadequate for this project, the Mood mean
scores before and after interventions were calculated as Mean=2.50 and M=.00, t (5)
=1.464, p=.203. Mean scores for Mood is not in true value scores but denotes the
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scoring mechanism of the tool, which is 00-27. The .00 not being statistical but
indicating the variance between the pre and post Means. These results suggest that the
Hand In Hand non-pharmacological training does not decrease the behavioral or
psychological symptoms in the elderly dementia residents or mood.

Table 2.
Results of Pre and Post Average Brief Interview of Mental Status Scores
PreBIMS

PostBIMS

(N)

6

(N)

6

Mean

7.483

Mean

4.750

SD

4.0975

SD

2.3611

t/df

(5)=3.064

p

.028

p<.05 for statistical significance
Major Findings
Due to the small sample size, these results suggest that the Hand In Hand nonpharmacological training does not decrease the behavioral or psychological symptoms in
the elderly dementia residents or mood and cognitive function decreased during the post
training. Similar results may not be reflective of a larger population sample.
The Pharmacy Review Summary report for pre-training intervention and post
training scores were averaged for three months. Resident records reviewed for three
months pre training (July, August, and September) were averaged and revealed that
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15.866 residents received atypical antipsychotic medications. Post training records for 3
months (October, November, and December) revealed that 15.773 residents received the
medications, a difference of .093. These results show very little change in the use of
medications, but also do not show an increase in administration of atypical antipsychotic
medications. Please refer to Table 3.
Table 3.
Pharmacy Review Summary Regarding Use of Atypical Antipsychotic Medications
Pharmacy Review Summary
Pre-Pharmacy Record: (3 months) Number Receiving
Atypical Antipsychotics Before Training
Post-Pharmacy Record: (3 months) Number Receiving
Atypical Antipsychotics After Training

15.2

16.1

16.3

15

16.2

16

Record of Patients Reviewed
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Summary
The retrospective chart review done on the project produced a small sample size
for the project. The small sample did produce statistically significant results using the
paired sample t test for the Brief Interview of Mental Status but not the Mood scores.
Pharmacy Review Summary revealed very little difference in atypical antipsychotic
medication administration for dementia residents. However, there was no increase in the
medication administration to the dementia residents post training intervention.
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CHAPTER V
Discussion
The capstone project was to determine relationship of the Hand In Hand
intervention to a decrease of behavior and psychological symptoms of dementia resident
in long-term care. Training was implemented in a long-term care facility with direct care
staff and pre and post data was collected on the Brief Interview of Mental Status (BIMS)
and Mood tools from the Minimum Data Sets (MDS). Descriptive statistical data was
done using the paired sample t tests on the BIMS and Mood data. Pharmacy Review
Summaries were also collected and averaged for pre and post training to determine any
changes in atypical antipsychotic medication administration.
Implication of Findings
Can non-pharmacological intervention training of direct care staff decrease
behavior and psychological symptoms in elderly dementia residents and potentially
demonstrate a need for reduction in atypical antipsychotic medication use?
The project results did show some difference in the mean of pre Brief Interview of
Mental Status (BIMS) and Mood scores when compared to post scoring. The BIMS
mean scores went down, indicating a decrease in the residents cognitive function level.
The Mood mean scores also went down, although paired sample size was inadequate, and
might be a possible indication of improved mood in the elderly dementia residents. One
finding that was small but important was that the administration of atypical antipsychotic
medications did not increase from the three months pre training and the three months post
training, based on the Pharmacy Review Summaries. This is important in the initiative to
monitor and decrease the use of these drugs, (Kohen, et al., 2010; Lindsey, 2009).
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The findings also mirror another project with non-pharmacological treatments; the
lack of rigorous scientific design (O'Neil et al., 2011). The project did not have a random
control design to produce empirical data. Training tools and evaluation tools from
Centers for Medicare and Medicaid Services (CMS), which did not produce a cost factor,
is an area missing in the literature on non-pharmacological treatments. Due to these tools
being indicated for use by CMS, this project did not add to the literature on costs.
Application to Theoretical/Conceptual Framework
The findings were congruent with the primary, secondary, and tertiary model
phases of Neuman’s Care Systems Model (Neuman Systems Model, 2013). The primary
prevention was on health promotion and the ability of direct care staff to recognize the
stressors that might trigger behavior and psychological symptoms in dementia residents.
The Hand In Hand training aided in the secondary line of prevention with a nonpharmacological intervention to help the resident react to internal and external stressors.
As the non-pharmacological interventions were implemented and reinforced by staff, the
tertiary prevention level was executed to help the resident adapt to change and return to a
wellness state. Betty Nueman’s Care System Theory was an appropriate framework for
the interventions utilized to help the residents manage stress, communicate effectively
and use other methods to help the resident adapt to changes in their environment and
maintain equilibrium.
Limitations
The findings of this project were impacted by the small sample size and limitation
of one nursing home. Availability of training time and staff numbers for training also
influenced the time for data collection. Unexpected administrative turnover in key areas
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related to education and data collection, delayed training and collection of data.
Additional projects with larger sample size, multiple nursing facilities, dementia units,
and various data collection methods may produce statistical significant outcomes for nonpharmacological interventions in dementia.
Another area for consideration is the development of tools for evaluating
symptoms that capture the data thoroughly, succinctly, and in multiple formats.
Documented on one Mood tool, the nurse had noted that the resident stated “I can’t hear
you! Oh just forget it”. This score then became a 99 because the resident refused to
complete the questions. When working with the elderly, nurses need to consider all the
sensory deficits and design a universal tool to use that works for alternative
communication needs.
Implications for Nursing
The results of this project have significance to nursing for improvement in the
person-centered care of the elderly dementia resident. Results have shown a need to
explore ways to improve the behavior and psychological symptoms in dementia (BPSD)
through non-pharmacological treatments using educational tools to help direct care staff.
The findings support the need for non-pharmacological intervention projects designed as
rigorous scientific methods to capture empirical data. If a transition to a nonpharmacological treatment of BSPD is to be achieved, then new protocols and modalities
of treatment need to be developed and supported by empirical evidence.
Recommendations
Additional projects and studies using the implementation of Hand In Hand
training for direct care staff, on dementia units in multiple facilities, would be helpful in
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adding to the statistical data. The need to extend the time frame for the study should
help to produce more significant data. Development of diverse tools for sensory deficits
and random controlled design could support the need for increased usage of nonpharmacological interventions in dementia care.
Conclusion
This project was done to show a correlation between the non-pharmacological
intervention Hand In Hand training and behaviors and psychological symptoms in elderly
dementia residents. The training was completed with 66% of direct care staff within the
long term nursing center. Collection of Brief Interview of Mental Status (BIMS) and
Mood data from the Minimum Data Sets were collected pre and post training and
descriptive statistics were used to analyze the data. Although statistical significance was
shown on the paired sample t test with the BIMS score, there was a decrease on the Mean
scores for pre and post scores which may denote a decline in cognitive function based on
the variance between Mean and the tools scoring criteria. This decrease in Mean mood
scores indicated a possible improvement after the training. More rigorous and empirical
testing is warranted to support conclusive results. However, the Pharmacy Review
Summaries did not show any increase in prescriptions for atypical antipsychotic
treatment for the dementia residents. The findings may indicate that direct care staff
used the non-pharmacological training in the daily care of the elderly dementia resident
and that conservative prescribing of atypical antipsychotic medications are also part of
the equation. This project adds to the essential need for more projects and studies in the
non-pharmacological treatment of behavior and psychological symptoms of dementia in
elderly residents.
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Appendix A
OIG Statistics on Off Label Atypical Antipsychotics Claims
Generic Name of Drug

Claims

Dollar Amount

Quetiapine

627,661

$85,847,131

Risperidone

536,600

$87,161,507

Olanzapine

356,695

$94,055,067

Aripiprazole

83,756

$29,565,887

Ziprasidone

44,681

$10,067,477

Clozapine

27,294

$1,691,718

Olanzapine/Fluoxetine

1,521

$431,799

Paliperidone

666

$207,731

Total

Source: (OIG Report, 2011)

Claims

Costs

1,678,874

$309,028,317
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Appendix B
Claims for Medicare of Atypical Antipsychotics (Number/Percentage)

Claim for drug indication

Number

Percentage

For off-label conditions

1,197,442

83.1%

In condition presence
specific to FDA box
warning
Off-label conditions and
with FDA warning

1,263,641

87.7%

1,088,260

75.5%

Off-label conditions and/or
specific FDA warnings

1,372,823

95.3%

Neither off-label or specific
FDA box warning
conditions present

68,277

4.7%

Total (net)

1,441,100*

100%

Records that were not
reviewed

237,744

n/a

Total Claims

1,678,874

n/a

Source: (OIG Report, 2011)
*Projection is based on reviewed records only and do not reflect size of population in
Appendix A
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Appendix C
Invalid Medicare Claims

Error Reasons

Number

Percentages

Dollar Amount

Drug claimed was
not documented*

3,808

0.3%

$559,333

Drug claimed was
not for medically
accepted use

722,975

50.2%

$115,919,685

Total errors

726,783

50.5%

$116,479,018

Source: (OIG Report, 2011)
*Undocumented claims for table completion. Three were undocumented which was too
low for 95% confidence interval statistically.
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Appendix D
Unnecessary Medical Claims by CMS Standards

Reasons for not
meeting CMS
Standards

Number

Percentage

Dollar Amount

Excessive dosage

150,106

10.4%

$36,050,851

Excessive time

135,199

9.4%

$29,369,213

No adequate
indicator for use

115,818

8.0%

$21,396,226

No adequate
monitoring
Adverse effects
present requiring a
lower or termination
of drug

110,949

7.7%

$18,150,616

67,923

4.7%

$11,479,869

Total (gross*)

579,994

40.2%

$116,446,775

Overlapping

262,023

18.2%

$53,251,792

Total (net)

317,971

22.1%

$63,194,984

Source: (OIG Report, 2011)
*Sums not exact due to rounding of numbers

